Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M

Reuters

08/01

Performant Healthcare Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M

Performant Healthcare, Inc. (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2556040815"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2556040815\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2556040815?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-01 20:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556040815","market":"fut","top_or_hot":-1,"title":"Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Performant Healthcare Reports <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PHLT\">Performant Healthcare, Inc.</a> (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPerformant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-01 20:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Performant Healthcare Reports <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PHLT\">Performant Healthcare, Inc.</a> (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHLT","symbol_name":"Performant Healthcare, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL2FYwc9:1","article_id":"2556040815","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556040815","pubTimestamp":1754051718,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Performant Healthcare, Inc.  has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PHLT":"Performant Healthcare, Inc."},"translate_title":"Performant Healthcare报告2025年第二季度收入为3780万美元，净利润为210万美元；调整后EBITDA为620万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHLT":0.9},"content_text":"Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n    \n\nPerformant Healthcare, Inc. (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}